Communiqués Polarean Imaging plc

Actions

POLX

GB00BF3DT583

Marché Fermé - London S.E. Autres places de cotation 17:40:42 21/06/2024			Varia. 5j.	Varia. 1 janv.
1,8 ^GBX	-16,28%		+35,85%	-71,20%

22/05	Powerhouse résout un litige ; PCI-PAL gagne un procès	AN
22/05	Polarean Imaging cherche à lever 10 millions de dollars grâce à la vente d'actions	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives	20/06	GL
Polarean’s Xenon MRI to be Featured at Upcoming ATS 2024 Conference	08/05	GL
Polarean Imaging "very excited" to announce brand new customer for XENOVIEW polariser	21/12	AQ
Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs	08/09/23	GL
Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs	08/09/23	AQ
Polarean Imaging : Interim Results for the six months ended 30 June 2023	07/09/23	PU
CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology	29/08/23	GL
CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology	29/08/23	AQ
Polarean Receives Clearance for New MRI Chest Coil	03/08/23	GL
Polarean Receives Clearance for New MRI Chest Coil	03/08/23	AQ
Appointment of Dr. Christopher von Jako as new CEO	21/06/23	GL
Appointment of Dr. Christopher von Jako as new CEO	21/06/23	AQ
Polarean Imaging : Annual Report & Accounts 2022 (inc. Notice of AGM)	26/05/23	PU
First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center	11/05/23	GL
Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit	03/05/23	GL
FDA Approves Polarean's XENOVIEW (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation	29/12/22	AQ
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation	28/12/22	GL
Polarean Imaging : Interim Results for the six months ended 30 June 2022	31/08/22	PU
Polarean Imaging : Interim Results for the six months ended 30 June 2021	02/09/21	PU
Polarean Imaging : “Polarean” or the “Company”) NDA Submission	07/10/20	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Polarean Imaging plc

Actions

POLX

GB00BF3DT583

Communiqués

Filtres